Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
ABT-751による持続投与レジメン
Document Type and Number:
Japanese Patent JP2007500240
Kind Code:
A
Abstract:
The invention relates to pharmaceutical compositions comprising combinations of ABT-751 and anti-cancer drugs. These combinations have additive antitumorigenesis activity. This invention also relates to methods of treatment using the combinations.

Inventors:
Gordon, Geary
Hajii, Ann Yi
Rosenberg, Saul H
Application Number:
JP2006533503A
Publication Date:
January 11, 2007
Filing Date:
June 01, 2004
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
ABBOTT LABORATORIES
International Classes:
A61K45/00; A61K31/00; A61K31/44; A61K31/635; A61P35/00; A61P43/00
Other References:
JPN6010029033, YAMAMOTO, K., et al., "Phase I study of E7010", Cancer Chemotherapy and  Pharmacology, 199807, Vol.42, No.2, p.127−134
JPN5006016140, HANDE, K., et al., "A Phase I trial of ABT−751, a novel microtublin Inhibitor", EUROPEAN JOURNAL OF CANCER, 200211, Vol.38, p.S42, GB, PERGAMON PRESS
JPN6010029038, KOYANAGI, N., et al., "In Vivo Tumor Growth Inhibition Produced by a Novel Sulfonamide, E7010, against Rodent and Human Tum", CANCER RESEARCH, 19940401, Vol.54, No.7, p.1702−1706
JPN6010029041, FUNAHASHI, Y., et al., "Effect of E7010 on liver metastasis and life span of syngeneic C57BL/6 mice bearing orthotopically t", Caner Chemotherapy and Pharmacolgy, 200102, Vol.47, No.2, p.179−184
JPN6010029048, HAYAKAWA, K., et al., "COLLABORATIVE WORK TO EVALUATE TOXICITY ON MALE REPRODUCTIVE ORGANS BY REPEATED DOSE STUDIES IN RATS", The Journal of Toxicological Sciences, 2000, Vol.25, Special Issue, p.173−178
Attorney, Agent or Firm:
Yoshio Kawaguchi
Makoto Ono
Kenkyo Kanayama
Katsuma Osaki
Mitsuaki Tsubokura